Virus Filtration Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3898
Virus Filtration Market size is projected to experience significant growth from 2019 to 2025.
Virus filtration market will witness tremendous growth over the projected timeframe due to the growing incidence of various chronic and infectious viral diseases such as hepatitis, Ebola, influenza, and other autoimmune disorders. According to the World Health Organization (WHO) estimates, in 2019, about 500 million individuals will be affected by hepatitis B or C in Europe. Also, these viruses kill 1.5 million individuals every year. Thus, rising number of these cases will fuel the market growth in the forecast period.
Growing demand for biological therapeutic products such as monoclonal antibodies, stem cell products, blood components, biologics, and vaccines will stimulate global virus filtration market business growth in the coming years. Virus filtration method is one of the most commonly used technique during the purification procedure to attain effective results and to ensure the safety of biological products. Additionally, advanced technological innovations such as Viresolve Pro Virus Filtration method provides an inclusive solution for viral clearance within monoclonal antibody and recombinant protein bioproduction. Aforementioned factors will offer lucrative growth opportunities in the estimation period.
However, high risk of contamination due to virus filter membrane may impede the growing adoption rate by various biopharmaceutical companies. Furthermore, stringent government regulations for validation of filtration products may limit product approvals, thereby hampering the virus filtration market growth in the forecast period.
Filters & filtration systems segment will hold significant revenue size over the forecast years due to its extensive features such as high efficiency and purity, cost-effectiveness, and does not denature the proteins during filtration. Further, these filters increase the processing capacity by delivering a high level of virus clearance, thereby boosting the demand for filtration systems in the coming years.
Biologics segment is expected to witness significant growth over the forecast period. Growing pervasiveness of chronic diseases such as blood disorders, cancer, diabetes, deficiency of growth hormones, and other autoimmune disorders that surge the demand for biologics. Also, rise in adoption of biotherapeutics owing to lesser adverse effects is estimated to drive the biological segment market growth over the forthcoming years.
Pharmaceutical and biotechnology segment will show high adoption rates owing to the accessibility of safe, beneficial, improved, and advanced virus filtration systems. These companies are persistently striving for the development of new biopharmaceutical products thus, increasing the demand for virus filtration market in the coming years. For instance, in October 2016, Merck KGaA received the U.S. FDA approval for Zinplava (bezlotoxumab), an antibacterial drug used for the treatment of clostridium difficile infection in adult patients. The above mentioned factors will offer lucrative growth opportunities to drive the segmental growth.
U.S. virus filtration market will show a momentous growth over the coming years due to the increasing incidence of various chronic diseases that require biological products. Presence of major biopharmaceutical and biotechnology companies in the U.S. will escalate the demand for innovative viral filtration products. Furthermore, stringent regulatory procedures for development of biologics will foster the U.S. market growth over the forecast period.
India virus filtration market is projected to foresee lucrative growth over the forecast period due to the presence of various developing pharmaceutical and biotechnology manufacturers. Growing awareness about the applications of biotherapeutics among the population will enhance the market growth. Moreover, increasing presence of contract research organizations (CROs) and availability of labor at low cost will offer rapid growth opportunities for market industry growth over forthcoming years.
Few of the major companies operating in virus filtration market share include Danaher, Asahi Kasei Medical Co., Ltd., BioProcess International, BIA Separations and Lonza among other players. These industry players focus on strategic initiatives such as new product launch, mergers & acquisitions, partnerships, and collaborations to expand their business portfolio and to enhance their revenue generation. For instance, in October 2016, Pall Life Sciences (Danaher) launched the Pegasus Prime filter membrane to simplify process development and manufacturing processes, providing enhanced viral safety. This strategy will expand the company’s existing the market product portfolio.
Virus Filtration Market by Type, 2014-2025 (USD Million)
- Filters & Filtration Systems
- Kits and Reagents
Virus Filtration Market by Application, 2014-2025 (USD Million)
- Vaccines & Therapeutics
- Blood and Blood Products
- Stem Cell Products
- Medical Devices
Virus Filtration Market by End-use, 2014-2025 (USD Million)
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Medical Device Companies
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Asahi Kasei Medical Co., Ltd.
- BioProcess International
- BIA Separations
- General Electric Company
- Merck KGaA
- Sartorius AG
- Sotera Health
- Synder Filtration, Inc.
- WuXi AppTec
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability